Post-transplant patients with COVID-19 associated acute respiratory distress syndrome, a role for Tociluzumab: A case series.

Ladna, M; Villanueva, F L; Maharrey, P B; Lascano, J

Ladna, M; Villanueva, F L; Maharrey, P B; Lascano, J.

Ladna M; Division of Internal Medicine, Department of Medicine, University of Florida, Gainesville, FL, United States.
Villanueva FL; Division of Internal Medicine, Department of Medicine, University of Florida, Gainesville, FL, United States.
Maharrey PB; Division of Internal Medicine, Department of Medicine, University of Florida, Gainesville, FL, United States.
Lascano J; Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of Florida, Gainesville, FL, United States.

Respir Med Case Rep ; 32: 101319, 2021.

Article en En | MEDLINE | ID: mdl-33318918

Palabras clave

Acute respiratory distress syndrome; COVID-19; Critical care; LIST, ARDS; Respiratory failure; Tocilizumab; acute respiratory distress syndrome, COVID-19; computerized tomography, IL; coronavirus disease of 2019, CT; interleukin, CAR-T cell: chimeric antigen receptor T-cell

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Año: 2021 Tipo del documento: Article